Characterization of polygalacturonases produced by the endophytic fungus Penicillium brevicompactum in solid state fermentation - SSF

Polygalacturonases belong to the family of pectinases, enzymes that are in high demand in industry because of their many different applications. This study therefore sought to examine the production of polygalacturonases using an endophytic fungus, Penicilium brevicompactum, isolated from Baccharis dracunculifolia D.C. (Asteraceae) through semi solid fermentation using orange peels and citric pectin 2% as base substrate, supplemented with different carbon sources. After the fermentation process, the enzyme was characterized. The results showed that the micro-organism was able to use a wide range of carbon sources, but with polygalacturonase activity varying with each source. The highest yield, however, was achieved after 30 hours of incubation in the presence of 4% of galactose and 2% of pectin. Studies on the characterization of the polygalacturonase revealed that the optimal temperature of this enzyme is 72°C and that it maintains 60 and 15% of its maximum activity when incubated for 2 hours at 40 and 90°C, respectively. The optimal pH for the activity of the enzyme was 4.6. The enzyme retained 65 and 30% of its maximum activity when incubated at pH 3.5 and 9.5, respectively, for 24 hours at ambient temperature. The enzyme activity was stimulated by Mg2+ ions. On the other hand, it was inhibited by the ions Cs+2, Hg+2, Li+2 and Sr+2. The ions Zn+2 and Cu+2 inhibited it by 94% and 69%, respectively

Expression of progesterone receptor membrane component-1 in bovine reproductive system during estrous cycle

Several reports suggest the participation of progesterone receptor membrane component 1 (PGRMC1) in progesterone signaling in the reproductive system. This study aimed at investigating the presence and localization of PGRMC1 in bovine ovary, oviduct and uterus, during the follicular and luteal phases of the estrous cycle. In the ovary, PGRMC1 has been detected in surface germinal epithelium, granulosa cells, theca cells and in the germinal vesicle of the oocytes at all stages of folliculogenesis. In the corpus luteum the expression of PGRMC1 was influenced by the stage of the estrous cycle. In the oviducts and in the uterus horns, PGRMC1 was immunolocalized in the luminal epithelium, in the muscle layer cells and in the endothelial cells. In the uterus, PGRMC1 was intensely localized also in the glandular endometrium. However, in the oviducts and in the uterus horns, the localization of PGRMC1 was independent on the stage of the estrous cycle and on whether evaluating the ipsilateral or the contralateral organ. In conclusion, the present immunohistochemical study showed that PGRMC1 is located in various compartments of the bovine female reproductive organs. With the exception of the corpora lutea, PGRMC1 localization showed similar pattern during different stages of the estrous cycle

On the relationship between functional encryption, obfuscation, and fully homomorphic encryption

We investigate the relationship between Functional Encryption (FE) and Fully Homomorphic Encryption (FHE), demonstrating that, under certain assumptions, a Functional Encryption scheme supporting evaluation on two ciphertexts implies Fully Homomorphic Encryption. We first introduce the notion of Randomized Functional Encryption (RFE), a generalization of Functional Encryption dealing with randomized functionalities of interest in its own right, and show how to construct an RFE from a (standard) semantically secure FE. For this we define the notion of entropically secure FE and use it as an intermediary step in the construction. Finally we show that RFEs constructed in this way can be used to construct FHE schemes thereby establishing a relation between the FHE and FE primitives. We conclude the paper by recasting the construction of RFE schemes in the context of obfuscation.NSF -National Science Foundatio

LNL irradiation facilities for radiation damage studies on electronic devices

In this paper we will review the wide range of irradiation facilities installed at the INFN Legnaro National Laboratories and routinely used for radiation damage studies on silicon detectors, electronic components and systems. The SIRAD irradiation facility, dedicated to Single Event Effect (SEE) and bulk damage studies, is installed at the 14MV Tandem XTU accelerator and can deliver ion beams from H up to Au in the energy range from 28MeV to 300 MeV. An Ion Electron Emission Microscope, also installed at SIRAD, allows SEE testing with micrometric sensitivity. For total dose tests, two facilities are presently available: an X-rays source and a 60Co γ-ray source. The 7MV Van de Graaff CN accelerator provides 1H beams in the energy range 2–7MeV and currents up to few μA for both total dose and bulk damage studies. At this facility, very high dose rates (up to ∼100 krad/s (SiO2)) can be achieved. Finally, also neutron beams are available, produced at the CN accelerator, by the reaction d + Be ⇒ n+B

“Three-bullets” loaded mesoporous silica nanoparticles for combined photo/chemotherapy

This contribution reports the design, preparation, photophysical and photochemical characterization, as well as a preliminary biological evaluation of mesoporous silica nanoparticles (MSNs) covalently integrating a nitric oxide (NO) photodonor (NOPD) and a singlet oxygen (1O2) photosensitizer (PS) and encapsulating the anticancer doxorubicin (DOX) in a noncovalent fashion. These MSNs bind the NOPD mainly in their inner part and the PS in their outer part in order to judiciously exploit the different diffusion radius of the cytotoxic NO and 1O2. Furthermore this silica nanoconstruct has been devised in such a way to permit the selective excitation of the NOPD and the PS with light sources of different energy in the visible window. We demonstrate that the individual photochemical performances of the photoactive components of the MSNs are not mutually affected, and remain unaltered even in the presence of DOX. As a result, the complete nanoconstruct is able to deliver NO and 1O2 under blue and green light, respectively, and to release DOX under physiological conditions. Preliminary biological results performed using A375 cancer cells show a good tolerability of the functionalized MSNs in the dark and a potentiated activity of DOX upon irradiation, due to the effect of the NO photoreleased

A novel training simulator for portable ultrasound identification of incorrect newborn endotracheal tube placement – Observational diagnostic accuracy study protocol

Background: Endotracheal tube (ETT) placement is a critical procedure for newborns that are unable to breathe. Inadvertent esophageal intubation can lead to oxygen deprivation and consequent permanent neurological impairment. Current standard-of-care methods to confirm ETT placement in neonates (auscultation, colorimetric capnography, and chest x-ray) are time consuming or unreliable, especially in the stressful resuscitation environment. Point-of-care ultrasound (POCUS) of the neck has recently emerged as a powerful tool for detecting esophageal ETTs. It is accurate and fast, and is also easy to learn and perform, especially on children.Methods: This will be an observational diagnostic accuracy study consisting of two phases and conducted at the Aga Khan University Hospital in Karachi, Pakistan. In phase 1, neonatal health care providers that currently perform standard-of-care methods for ETT localization, regardless of experience in portable ultrasound, will undergo a two-hour training session. During this session, providers will learn to detect tracheal vs. esophageal ETTs using POCUS. The session will consist of a didactic component, hands-on training with a novel intubation ultrasound simulator, and practice with stable, ventilated newborns. At the end of the session, the providers will undergo an objective structured assessment of technical skills, as well as an evaluation of their ability to differentiate between tracheal and esophageal endotracheal tubes. In phase 2, newborns requiring intubation will be assessed for ETT location via POCUS, at the same time as standard-of-care methods. The initial 2 months of phase 2 will include a quality assurance component to ensure the POCUS accuracy of trained providers. The primary outcome of the study is to determine the accuracy of neck POCUS for ETT location when performed by neonatal providers with focused POCUS training, and the secondary outcome is to determine whether neck POCUS is faster than standard-of-care methods.Discussion: This study represents the first large investigation of the benefits of POCUS for ETT confirmation in the sickest newborns undergoing intubations for respiratory support